Company CVAbout Alkem Laboratories Ltd 
Alkem Laboratories Ltd
Large Cap
Pharmaceuticals & Drugs
Headquartered in Mumbai, India, Alkem Laboratories Limited is a leading Indian pharmaceutical company with global operations. The company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals, which it markets in India and international markets.
Company Coordinates
Company Details
Alkem House SenapatiBapat Marg, Lower Parel Mumbai Maharashtra : 400013
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 23.91 Cr
Number of Shares
11.96 Cr
Face Value
INR 2.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
23-Dec-2015
11.96
23.91
12853442
2
Public Issues
23-Dec-2015
11.96
23.91
12853442
2
Public Issues
22-Dec-2015
10.67
21.34
-12853442
2
Offer For Sale
22-Dec-2015
10.67
21.34
-12853442
2
Offer For Sale
16-Mar-2015
5.98
11.96
47826000
2
Stock Split
16-Mar-2015
11.96
23.91
59782500
2
Bonus
16-Mar-2015
5.98
11.96
47826000
2
Stock Split
16-Mar-2015
11.96
23.91
59782500
2
Bonus
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 28 Schemes (14.01%)
FIIs
Held by 460 FIIs (10.15%)
Promoter with highest holding
Sarandhar Singh* (please Refer Notes) (19.95%)
Highest Public shareholder
Icici Prudential Multi-asset Fund (3.65%)
Individual Investors Holdings
15.9%
Board of Directors
Management
Designation
Remuneration
Basudeo N Singh
Executive Chairman
19.25 cr
SANDEEP SINGH
Managing Director
8.27 cr
Mritunjay Kumar Singh
Executive Director
9.59 cr
A K Purwar
Non-Exec. & Independent Dir.
31.0 lacs
SANGEETA KAPILJIT SINGH
Non-Exec. & Independent Dir.
32.0 lacs
SUDHA RAVI
Non-Exec. & Independent Dir.
29.0 lacs
Manish Narang
Company Sec. & Compli. Officer
0
Dheeraj Sharma
Non-Exec. & Independent Dir.
31.0 lacs
Narendra Aneja
Non-Exec. & Independent Dir.
30.0 lacs
SARVESH SINGH
Executive Director
4.33 cr
Madhurima Singh
Executive Director
9.5 cr
Sujjain Talwar
Independent Director
19.0 lacs
Srinivas Singh
Executive Director
5.72 cr
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Other Operating Revenues
82.73
1.39%
Other Operating Revenues
Other Operating Revenues
Stock DNARevenue and Profits:
Net Sales:
3,374 Cr
(Quarterly Results - Dec 2024)
Net Profit:
626 Cr
Pharmaceuticals & Drugs
INR 58,288 Cr (Large Cap)
27.00
33
0.87%
-0.07
18.97%
5.04
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
